FDA meeting to plan for future flu vaccines mysteriously canceled

FDA meeting to plan for future flu vaccines mysteriously canceled - The decision comes amid the worst flu season in 15 years ...

FDA reverses course, will review Moderna’s mRNA flu vaccine candidate

The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA ...
Food Allergy Research & Education (FARE)

FARE to Represent the Food Allergy Patient Voice in Upcoming FDA Expert Panel on Food Allergies

Following FARE’s Participation in FDA’s Virtual Public Meeting on Food Allergen Thresholds and Public Listening Sessions, FARE CEO Sung Poblete, PhD, RN, to Join Scientific and Clinical Experts at the ...

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry Products and leadership of ...

NRx Builds Momentum From FDA Progress To Strategic Expansion

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...
Benzinga.com

Adial Pharmaceuticals Highlights Favorable Comments From FDA Meeting For Lead Program In Alcohol Use Disorder

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) on Tuesday received the final meeting minutes from its End of Phase 2 (EOP2) Meeting with the U.S. Food and Drug Administration (FDA) held in July. The ...